New chlorophyll derivatives (pheophytins along with pheophorbide derivatives) were isolated from the leaves of Ficus exasperata and were found to have varying effects on uterine contractility. The current study was therefore aimed at the utilization of mass spectrometry and nuclear magnetic resonance spectroscopy coupled with isolated uterine tissue assay as a platform to assist in the determination of the mechanism of activity of the isolated chlorophyll compounds from the plant F exasperata. The pheophytin and pheophorbide compounds (200 mg/mL) were added to the isolated uterine tissues. Mice uteri, treated with the pheophytin compounds, and the physiological buffer in which the uterine tissues were immersed, were rapidly collected and analyzed using high-resolution Fourier transform mass spectrometry and proton ( 1 H) nuclear magnetic resonance for bioinformatics study. Resulting data were analyzed via pairwise chemometric comparison models, with P < .05 considered statistically significant. Primary signaling pathways found to be correlated with the pheophytins in this study included cyclic adenosine monophosphate, dopamine, extracellular signal-regulated kinases 1/2, and glutamate pathways.
Introduction
New chlorophyll derivatives (pheophytins along with pheophorbide-a derivatives) were isolated from the leaves of Ficus exasperata and were found to have varying effects on uterine contractility. These new pheophytins included compound In our previous study, pheophorbide-a derivatives at concentrations of 70 to 200 mg/mL were mainly observed to reduce the amplitude but increase the frequency of uterine contractions 1 ; this was similarly observed in fraction 6-17 (C3-5). However, fraction 4-31 (C6) inhibited uterine contractions. 1 The short-chain pheophorbide-b derivatives exerted both a stimulatory and inhibitory effect on spontaneous uterine contractions while inhibiting oxytocin (OT)-induced uterine contractions. 1 Due to low available yields of the compounds at the stage of structure elucidation, it was impossible to continue with further characterization of the uterine activities of the compounds. Metabolomic investigation was therefore performed to enable characterization of activities due to the low quantities available. Metabolomics which involve the use of high-resolution Fourier transform mass spectrometry (HRFTMS) and 1-D/2-D nuclear magnetic resonance (NMR) enabled the study of changes in metabolomic profile, which are produced by living tissues. 2, 3 Metabolites have been described as functional units within cells, which are released in response to signals or stimuli. Measurement of these metabolites therefore can assist in the understanding of basic and underlying mechanisms related to metabolic actions. 4 Biofluids and/or tissues can be sampled for metabolomic analysis measurement, and in such instances, these samples can be used to investigate specific information associated with the tissue or organ while the study of biofluids can provide a projection of the metabolic changes that have occurred within organs or tissues. 5 This study was, therefore, aimed at the use of metabolomic techniques coupled with functional ex vivo uterine assay as a platform to determine fluxes in metabolite profiles during treatment with pheophytins isolated from F exasperata. Knowledge of these changes in metabolomics profiles can provide more information into the mechanism(s) of activity of the chlorophyll derivatives on uterine contractility.
Materials and Methods

Animals
Female C57BL/6 strain laboratory mice weighing between 20 and 30 g, obtained from the Biological Procedures Unit of the University of Strathclyde, United Kingdom, were used in this study. The animals were maintained in a controlled environment and in an air-conditioned room at 25 C, 60% relative humidity under a 12/12-hour cycle of light and dark with free access to food and water.
All experiments were carried out in accordance with the Animal Health and Welfare (Scotland) Act 2006 and the Public Health Service Policy on Humane Care and Use of Laboratory Animals 2002. Mice were euthanized under rising concentration of CO 2 and exsanguinated before excision of the uterine tissues. Contractility experiments. Methods described previously by Bafor and colleagues were employed. 1 Briefly, mice in proestrous and estrous stages were used. Contractility experiments were performed on the dissected uteri, which were cut into segments of approximately 0.5 to 0.8 cm in longitudinal length, cleaned of extra connective tissues to provide 4 preparations per mouse. The segments were then weighed and subsequently mounted in warmed (37 C) 3 mL organ baths containing normal Krebs-Henseleit physiological solution which was composed of 118.4 NaCl, 25 NaHCO 3 , 11.1 glucose, 4.69 KCl, 2.41 MgSO 4 , 1.18 KH 2 PO 4 , 2.5 CaCl 2 (mM), and continuously gassed with carbogen (95% O 2 , 5% CO 2 ).
Tissues were set up with an initial tension of 1 g and equilibrated for 30 minutes before the start of the experiments. The force and frequency of spontaneous contractions in the longitudinal muscle layer were recorded through Grass (FTO3) isometric force transducers connected via Quad Bridge modules to a PowerLab 4/20 data acquisition system using Chart 3.3 software (AD Instruments, Oxford, United Kingdom) which was used to store and analyze acquired data.
Concentration-Response Studies
Single concentrations (200 mg/mL) of C3-5 which were eluted as a mixture (ficusphytin-a1 and a2, and pheophytin-a) or C6 (pyropheophorbide-a) were added to the bath for 10 minutes following stable rhythmic spontaneous contractions. This concentration was selected as the maximum concentration for observation of activity based on the previous study. Without washing and while the compounds were still in the organ bath, the uterine tissues were rapidly collected after 10 minutes, placed into preweighed cryovials and immersed in liquid nitrogen for 20 seconds. This was done in order to snap freeze the tissues and keep the internal environment of the metabolites in the tissues intact. Snap freezing is critical for experiments where it is necessary to retain the activity within a biological sample at a specified period, as it prevents the cells responding to any handling perturbation. 6 Bath fluids where the tissues were immersed were similarly collected (3 mL) and snap frozen. All samples were subsequently stored at À80 C prior to further experiments. Four animals each for individual experiments were employed. All graphs were prepared using Prism Software (version 4; GraphPad Software, California).
Tissue Metabolite Extraction
All samples were placed in dry ice after retrieval from the À80 C freezer. Each snap-frozen tissue was homogenized in 400 mL cold methanol (MeOH) using a homogenizer (IKA-WERKE GmbH & Co, Staufen im Breisgau, Germany). The homogenate was vortexed for 60 seconds before being centrifuged at 13 000 rpm for 5 minutes per tissue sample extracted with MeOH (samples extracted with MeOH were subsequently referred to as the "polar extracts"). The supernatant was collected using a micropipette syringe and dried in preweighed vials in preparation for further NMR and MS measurements. Using the same homogenized tissue residue, the process was repeated with 400 mL cold dichloromethane (DCM) and centrifuged at 13 000 rpm for 10 minutes. Tissues extracted with DCM were subsequently referred to as the "nonpolar extracts." The time periods employed for centrifugation were predetermined from preliminary experiments. All extracts were freeze dried and corresponding weights were recorded.
Bath Fluid Metabolite Extraction
Each fluid sample was freeze dried in a freeze drier (Christ Alpha 2-4; SciQuip, Newton, Wem, United Kingdom) and weighed. The dried samples were then reconstituted with 500 mL of cold MeOH and vortexed for 1 minute. The solution was pipetted out and centrifuged as previously described for polar extracts. The process was repeated with 600 mL cold DCM on the residue obtained after MeOH extraction. The entire extraction procedure was performed under cold conditions with samples placed in dry ice at all times. All samples were freeze dried as previously described and weighed.
H-NMR Data Acquisition
The dried polar extracts were weighed and reconstituted in 200 mL dimethyl sulfoxide vortexed for 30 seconds and submitted for 1-D 1 H-NMR measurements while the DCM extracts (nonpolar extracts) were weighed and reconstituted in 200 mL CDCl 3 and similarly submitted for 1-D 1 H-NMR measurements. Presaturated 1 H-NMR experiments were carried out on a JEOL-LA400 FT-NMR spectrometer system (JEOL Ltd, Welwyn Garden City, United Kingdom) with an AS400 magnet and measured at 400 MHz for 1 H using a pulse field gradient "Autotune" 40TH5AT/FG broadband high sensitivity 5 mm probe. Samples were measured in a 3-mm NMR tube with a 5-mm tube adapter.
1 H-proton NMR with presaturation of the residual water resonance were obtained using the following parameters: 32k data points, spectral width of 5998.4 Hz, acquisition time of 2.73 seconds, relaxation delay of 3.0 seconds, and pulse width of 5.47 requiring 3.85 minutes total acquisition time.
High-Performance Liquid Chromatography-HRFTMS Data Acquisition
Extracts of tissues and samples were also submitted for HRMS analysis. Polar extracts were reconstituted with 200 mL of 100% MeOH while the nonpolar extracts were reconstituted in DCM:MeOH at a ratio of 30:70. The 30:70 ratio was predetermined from preliminary experiments as best suited for dissolving the nonpolar extracts. Details of the highperformance liquid chromatography (HPLC) analysis can be obtained from the supplementary data.
Data Processing and Analysis
High-Performance Liquid Chromatography-HRFTMS Profiles
The HPLC-HRFTMS metabolic profiles of polar and nonpolar extract-treated tissues and surrounding bath fluids were analyzed for changes in metabolites before and after drug treatment as previously described. 7 Statistical determination was performed as previously described 7 in XCMS using the t test with P < 0.05 considered significant for each pairwise comparison of control and treated groups. Identification of metabolites within XCMS online was done using METLIN (Scripps Research Institute, La Jolla, CA, USA) (a web-based database).
Details of the profiling can be obtained from the supplementary data.
Bioinformatic Analysis of HPLC-HRFTMS Data
The Ingenuity Pathway Analysis (IPA) bioinformatics tool (produced by Ingenuity Systems, Redwood City, California) was used to perform bioinformatic analysis on resulting data. A search was additionally performed for regulated pathways with the aid of identified metabolites. Statistical significance was calculated using Fischer exact test; P < .05 was considered statistically significant. IPA automatically generates pathways related to specific metabolites for a given data set.
Nuclear Magnetic Resonance Preprocessing and Analysis
All NMR data sets were preprocessed using Mnova version 10.1. The imported spectra were manually phased and binned between d .5 and 10 ppm at bin value of d .04 ppm width. Residual water and solvent peaks were removed. The total spectra area was then normalized to a total value of 100 and a 2-dimensional matrix (n Â d) was created which was then exported into SIMCA version 14.0. Mean centering was performed before principal component analysis (PCA), and Orthogonal partial least squares-discriminant analysis (OPLS-DA) were applied to the data sets. Potential outliers as well as similarities between the metabolic fingerprints were enabled by PCA, and this usually occurs in an unsupervised manner. The S-line was also used in this study which functions as statistical total correlation spectroscopy. 8 Diagrammatic summary of the methods described above are presented in Figure 1 .
Results
Pharmacological Analysis
C3-5 and C6 were observed to decrease uterine contractility ( Figure 2 ). Data analysis of C3-5 showed a reduction in the amplitude (P < 0.05), frequency, and area under the curve of uterine contractions ( Figure 3) . Similarly, data analysis of C6 showed a reduction in the amplitude, frequency, and area under the curve (P < 0.05) of uterine contractions; however, the effect on frequency was less marked (Figure 4 ).
High-Performance Liquid Chromatography-HRFTMS of Pheophytin and Pheophorbide Compounds (C3-5 and C6)
High-resolution Fourier transform mass spectrometry experiments were analyzed using the multivariate analysis in SIMCA 14.0 and the bioinformatics software IPA as previously described. 7 Multivariate OPLS-DA plots showed distinct separations between the control (blue circles) and treated (red circles) groups of C3-5 (Supplemental Figure S1 ) and C6 (Supplemental Figure S2) . Multivariate S plots were also generated, which represented every metabolite detected within the groups compared. Significantly, regulated metabolites and pathways were also displayed as blue in the control and red in the treated (Figures 5 and 6 ). Cyclic adenosine monophosphate (cAMP), endocannabinoid, and catecholamine signaling were upregulated while myoinositol (MI) was downregulated ( Figures 5 and 6 ) in both C3-5-and C6-treated groups. Other detected metabolites were listed in Supplemental Tables 1 and 2 . These metabolites ranged from amino acids to lipids and included an increase in adenosine, cysteinyl dopamine, phosphatidylethanolamine, glycerol phosphate, phosphatidylserine, and triglycerides, which were observed in the tissues and fluids while a decrease in noradrenaline, tyrosine, and phosphatidylinositol were observed in C3-5-treated tissues and fluids (Supplemental Table 1 ). For C6-treated groups, an increase in threonine and adenosine was observed in the tissues and fluids while a decrease in g aminobutyric acid (GABA), glutamate, tyrosine, methionine, threonine, and phenylalanine was detected in the tissues (Supplemental Table 2 ). Metabolites detected in the fluids included an increase in nicotinic acid, uridine 5
00 -ulose, cysteinyldopamine, and ceramide, whereas MI, sphingosine, phosphatidylinositol, and phosphatidic acid were observed in the bath fluids to have been decreased (Supplemental Table 2 ).
The IPA bioinformatic software showed cell signaling, lipid metabolism, small molecule biochemistry, and nucleic and amino acid metabolism as high-level functions associated with both C3-5 and C6 mechanisms (Figures 7 and 8 ). Canonical pathways generated by IPA displayed MI signaling, cytidine diphosphate diacylglycerol (DAG), and serotonin pathways to be associated with the effect of both C3-5 Bar graphs representing data analysis of C6 on mouse uterine contractility. C6 was shown to inhibit the amplitude (A) and shown to produce a slight inhibition of the frequency (B) of uterine contraction. Overall, an inhibitory effect of C6 was observed as depicted in the AUC (C). n ¼ 4 animals, *P < 0.05. AUC indicates area under the curve analysis.
and C6 on uterine contractility (Figures 7 and 8) . However, nicotinic acid, eicosanoid, and GABA pathways were also found associated with the effect of C6 on uterine contractility ( Figure 8 ).
H-NMR Analyses of C3-5 and C6
Multivariate OPLS-DA showed distinct separations between the control and treated groups (Supplemental Figures S3 and  4) . For C3-5 groups, correlation coefficient plots of the 1 H-NMR measurements showed Ras homolog gene family member A (RhoA), nucleic acid, and cAMP signaling to be detected in the control tissues and bath fluids ( Figure 9 ) while endocannabinoid and DAG signaling were detected in the treated tissues and bath fluids (Figure 9 ). For the C6 groups, the correlation coefficient plots of the 1 H-NMR measurements also indicated the presence of metabolites for endocannabinoids signaling in both control and treated groups ( Figure 10 ). g Aminobutyric acid signaling was detected in the control while catecholamine and cAMP signaling were detected in the treated groups ( Figure 10 ). Other metabolites detected in C3-4-treated groups included glutamine and tyrosine which were detected to have been upregulated in the uterine tissues, whereas anandamide (AEA), glutamate, aspartate, glutamine, and phenylalanine were upregulated in the bath fluids (Table  2) . Arachidonic acid (AA), AEA, MI, DAG, and adenosine triphosphate (ATP) were detected to have been downregulated in the uterine tissues; these were similarly observed in the bath fluids, but in addition GABA, tyrosine, phenylalanine, and threonine were downregulated (Table 2 ). In C6-treated groups, other metabolites detected were adenosine, glutamate, DAG, adenosine monophosphate, AEA, and aspartate, which were upregulated in the tissues while glutamine, ATP, and GABA were detected as upregulated in the bath fluids. Adenosine triphosphate and AA were observed to have been downregulated in the tissues and in the bath fluids and in addition MI, DAG, prostaglandin F 1 , AEA, and threonine were downregulated in the bath fluids (Table 3 ).
Discussion
The properties of contractility throughout the mouse estrous cycle has been characterized sufficiently. 9 Contractility of the mouse uterus varies considerably across the 4-to 6-day estrous cycle, with particular contractility patterns predominating at the different stages. It has been reported that despite considerable variability in contractile behaviors, there are certain motility patterns that are more prevalent at each phase of the cycle; changes that may be due to the cyclic variation in the levels and receptor expression of the ovarian steroid hormones (oestrogen and progesterone), which have been shown to modulate spontaneous contractility in vitro. [10] [11] [12] Proestrous, the phase of follicular development, has been reported to exhibit mostly subtle contractions. At estrous, contractions have been reported to be slower, stronger events, which has been presumed to be primarily responsible for propelling a released ovum toward the uterine horn. 9 Earlier reports 13 described the secretory phase (estrous phase) to be characterized by slow, fluctuating contractions with superimposed small, fast, frequent contractions. The contraction pattern described was very similar to that observed in the current study prior to compound administration. There were no differences observed in the activity of the compounds during either cycle phases which may have been due to a relative consistency in the contractions occurring during the proestrous and estrous phases, as described earlier. By maintaining particular cycle stages throughout the experiment duration, we were able to minimize fluctuations arising from other phases allowing for consistency of results obtained. Nonetheless, a few extrapolations can be made from the compound activity during the stages used. By inhibition of contractions in the estrous phase of the nonpregnant uterus, compound C6 can contribute to inhibition of successful ovulation and may be useful in contraceptive therapies. Inhibition of contractions in the proestrous phase also limits the chances of ovum release prior to ovulation, contributing to possible contraceptive activity. For C3-5 which promoted increased frequency of contractions in either of proestrous or estrous phases suggests possible contribution to ovum release and propulsion toward the implantation sites and may therefore be useful for promoting or improving fertility in the nonpregnant uterus.
The chlorophyll compounds (C3-5 and C6) that affected the contraction of uterine tissue were observed to increase the metabolites for the cAMP pathway, as detected by both MS and NMR. An increase in myometrial cAMP concentration often results in inhibition of uterine contraction. Earlier reports had shown that cAMP inhibited OT-induced rat uterine contractility, an effect reported to occur possibly through inactivation of calcium ions.
14 However, there has been studies to suggest that OT stimulates adenylate cyclase activity in the endometrium. 15 More recent reports indicated that in early pregnancy, cAMP acts via protein kinase A (PKA) to decrease OT receptor (OTR) expression, whereas in the onset of labor, cAMP in the absence of PKA increases OTR expression. 16 These findings support a role for cAMP in myometrial contractility and in the regulation of OT-induced myometrial contractility. Glutamate signaling"
Abbreviations: cAMP, cyclic adenosine monophosphate; DAG, diacylglycerol; ERK, extracellular signal-regulated kinase; GABA, g aminobutyric acid; MI, myoinositol; ND, not detected; NMR, nuclear magnetic resonance; RhoA, Ras homolog gene family member A; ", increase; #, decrease. Myoinositol signaling decreased upon C3-5 and C6 treatment. Myoinositol generates several functional metabolites besides IP 3 , which may play a role in smooth muscle relaxation through inhibition of IP 3 or calcium uptake. Based on the results from this study, it is therefore proposed that a decrease in IP 3 contributed in part to the pharmacological effect seen in this study of the chlorophyll compounds C3-5 and C6 on myometrial contraction.
An increase in GABA signaling was observed with C6 but not with C3-5 where a decrease in GABA was observed. g Aminobutyric acid has been described to activate GABA B to elicit excitatory responses in the rabbit uterus, 17 whereas activation of GABA A receptors in the uterus promotes inhibition of uterine contractility and has been proposed to play a role in the modulation of uterine contractility. 17, 18 In this study, catecholamine synthesis was decreased upon treatment of the uterus with the chlorophyll compounds (C3-5 and C6). This observation suggested that catecholamines may not play significant roles in the effect of ficusphytins on uterine contraction.
The endogenous cannabinoids (endocannabinoids) were also found to be perturbed upon treatment of the uterus with ficusphytins. Endocannabinoids were increased on C3-5 treatment, whereas a decrease was observed upon treatment of uterine tissues with C6. The endocannabinoids, AEA, or Narachidonoylethanolamide has attracted special interest because of its marked biological activities. Anandamide has so far been the most extensively characterized N-arachidonoylethanolamine (NAE), which functions as an endogenous ligand of cannabinoid receptors and transient receptor potential vanilloid 1 channels. Endocannabinoids have been found in the uterus with one of the highest levels detected in the mouse uterus 19 and has also been implicated in the regulation of the female reproductive cycle especially with the presence of cannabinoid receptors in the uterus. 20 There have been a couple of investigations into the effects of endocannabinoids on uterine contractions. However, there are also contradictory reports on the effect of endocannabinoids on uterine contractility. Dennedy et al reported a relaxant effect of AEA on uterine contractility and demonstrated that this relaxant effect may be linked to a reduction in uterine prostaglandin synthesis. 21 In contrast, an increase in the force of spontaneous uterine contraction was reported for the endocannabinoids, 22 which was purportedly due partly to a cannabinoid-induced production of PGE 2 and Prostaglandin F2alpha (PGF) 2a , resulting in a decrease in the intracellular concentration of cAMP. 23 Similarly, some seemingly contradictory reports on the mechanisms of action of endocannabinoids exist. Some researchers report on a direct regulation of uterine contraction via binding with CB 1 and CB 2 receptors that preferentially couple to inhibitory G ai/o proteins to inhibit adenylate cyclase activity and consequently reduce intracellular cAMP levels. 24 Yet some researchers report on an observed increase in cAMP levels following CB 1 activation, 25 suggesting a possible coupling to Ga s of the G protein receptors. Other signaling events, including increased activity of MAPK, inhibition of voltage-gated Ca 2þ channels, activation of K þ channels, and nitric oxide generation, have also been suggested to follow CB receptor subtypes activation under different conditions. 23 It may seem, therefore, that binding of endocannabinoids to their receptors can result in activation/regulation of a number of signal transduction pathways, which are dependent on the agonist involved and the factors in place upon binding. Endocannabinoids exert a highly These pathways were found to be strongly correlated with the activity of C6. n ¼ 4 animals. cAMP indicates cyclic adenosine monophosphate; DAG, diacylglycerol; GABA, g aminobutyric acid; MI, myoinositol; NMR nuclear magnetic resonance; RhoA, Ras homolog gene family member A.
complex network of interactions, 26 which may probably extend its role in modulating uterine contractions as well as its role in the mechanism of uterine activity of the ficusphytins in this study.
Dopamine was also detected to contribute to the effects of the ficusphytins on uterine contractions. Uterine contraction increased on C3-5 treatment. Dopamine has been reported to inhibit uterine contractions in the nonpregnant uterus via action on adrenergic receptors. 27, 28 However, at early and term pregnancy, dopamine has been reported to stimulate myometrial contractility. [29] [30] [31] Dopamine can exert different and opposing effects on organs or tissues, and this observation has been associated with the species involved as well as the receptors present since dopamine is known to act on both dopaminergic and adrenergic receptors. 28 Endogenous dopamine has been previously detected in the uterus. 32 Ras homolog gene family member A signaling was also detected in this study. A decrease was detected on treatment with C3-5. The role of the small G protein RhoA (a member of the Rho subfamily of the Ras superfamily of monomeric GTPases) in the regulation of myometrial contractility has recently received considerable attention. Small G protein RhoA has been described to be involved in agonist-induced Ca 2þ sensitization by acting downstream on receptor occupancy, 33 as it has been shown to increase myosin light chain phosphorylation at a constant Ca 2þ concentration. 34 Inactivation of RhoA, therefore, would inhibit Ca 2þ sensitization. RhoA and repressor, open reading frame, kinase (ROK) have been shown to be involved in OT-induced myometrial contractility. 35 Thus, a reduction in RhoA would result in the inhibition of myometrial contractility.
Extracellular signal-related kinases (ERK) signaling was detected in this study to have been increased on C3-5 treatment of uterine smooth muscle, but a decrease was observed with C6. The involvement of the ERK pathway has been proposed to play a role in the regulation of agonist-induced smooth muscle contraction, activation of which has been shown to stimulate contraction. [36] [37] [38] [39] Extracellular signalrelated kinases also seems to be involved in spontaneous uterine contractility. 40 Extracellular signal-related kinases pathway has been shown to be involved in OT-induced uterine contraction 41 as well as prostaglandin F 2a -induced uterine contraction 42 and has been proposed to exert its effect by phosphorylation of caldesmon. 36 Therefore, activation of ERK would lead to an increase in contraction as exhibited with C3-5, and a decrease in ERK would lead to inhibition of uterine contractility as observed with C6.
Conclusion
The chlorophyll compounds in fraction C3-5, acted primarily by its interaction with cAMP, dopamine, ERK1/2, and glutamate. Possible connection with other catecholamines, prostanoids, MI, RhoA, and GABA was also suggested. While the chlorophyll compounds in fraction C6 acted primarily by its interaction with cAMP, sphingosine, glutamate, and GABA, possible connection with catecholamines, endocannabinoids, ERK1/2, RhoA, DAG, and MI was also postulated. An indepth understanding of signal transduction pathways discovered from this study could therefore provide a significant aid in the design of compounds such as those isolated from F exasperata and might prove useful in the treatment and prevention of uterine disorders. assistance in the HRESIMS measurements. Supporting data can be found in the Supplemental materials.
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